Filter
529
Filtered Results: 529
Text search:
molecular
markers
Featured
Recommendations
68
New Publications
104
Language
Document type
No document type
242
Guidelines
112
Studies & Reports
98
Manuals
36
Strategic & Response Plan
18
Fact sheets
10
Training Material
7
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
43
Global
23
Africa
14
Latin America and the Carribbean
13
Kenya
12
Tanzania
12
Western and Central Europe
12
Ethiopia
8
Eastern Europe
8
South Africa
7
South–East Asia Region
6
Philippines
5
East and Southern Africa
5
West and Central Africa
5
Sierra Leone
4
Nigeria
4
Uganda
4
Zimbabwe
4
Indonesia
4
Western Pacific Region
4
Asia
4
Cameroon
3
Nepal
3
Pakistan
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
USA
2
Zambia
2
Syria
2
Benin
2
Ukraine
2
Middle East and North Africa
2
Venezuela
2
North America
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Somalia
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Cambodia
1
Thailand
1
China
1
Rwanda
1
Malaysia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Angola
1
Lesotho
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Japan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
97
Public Health
38
Pharmacy & Technologies
24
Key Resources
14
Women & Child Health
12
Capacity Building
4
Toolboxes
TB
75
COVID-19
56
AMR
48
HIV
36
NTDs
31
Rapid Response
29
Mental Health
28
Planetary Health
17
NCDs
14
Ebola
10
Refugee
8
Pharmacy
8
Polio
5
Zika
5
Specific Hazards
4
Cholera
3
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Natural Hazards
2
Health Financing Toolbox
1
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
29 September 2021
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
